The Cancer Biopsy market size is USD 35.8 Bn in 2026.
The Cancer Biopsy market is projected to grow at a CAGR of 6% by 2033.
The Cancer Biopsy market growth drivers include rising cancer incidence, growing geriatric population, and rapid advancements in diagnostic technologies such as liquid biopsy and molecular testing.
North America is a dominating region for Cancer Biopsy market.
Hologic, Inc., Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Danaher Corporation, and F. Hoffmann-La Roche Ltd (Roche Diagnostics) are some leading industry players in the Cancer Biopsy market.